AVX avexa limited
Add to My Watchlist 0.00% ! 2.5¢

aus fin review

  1. cortinaboy
    1,203 Posts.
    lightbulb Created with Sketch. 66
    clock Created with Sketch.
    16/03/07
    07:56
    Post #: 2274193
    All looks good for Monday with a great article in this morning's Fin Review that says the Phase IIb trial of its apricitabine (ATC) drug has produced a better than hoped for results. Also speculates that Avexa will announce a capital raising of about $25 million. The journalist says that Avexa could be sitting on a pharmaceutical goldmine.
    AVX Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.